Folgen
Ish Khanna
Ish Khanna
NeuroPn Therapeutics
Bestätigte E-Mail-Adresse bei neuropn.com
Titel
Zitiert von
Zitiert von
Jahr
Drug discovery in pharmaceutical industry: productivity challenges and trends
I Khanna
Drug discovery today 17 (19-20), 1088-1102, 2012
5722012
Substituted pyrazolyl benzenesulfonamides
JJ Talley, TD Penning, PW Collins, DJ Rogier Jr, JW Malecha, ...
US Patent 5,466,823, 1995
3131995
1, 2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents
IK Khanna, RM Weier, Y Yu, XD Xu, FJ Koszyk, PW Collins, CM Koboldt, ...
Journal of medicinal chemistry 40 (11), 1634-1647, 1997
2651997
1, 2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2
IK Khanna, RM Weier, Y Yu, PW Collins, JM Miyashiro, CM Koboldt, ...
Journal of medicinal chemistry 40 (11), 1619-1633, 1997
2581997
1, 2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
IK Khanna, RM Weier, PW Collins, Y Yu, X Xu, RA Partis, FJ Koszyk
US Patent 5,616,601, 1997
2561997
Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
JJ Talley, JW Malecha, S Bertenshaw, MJ Graneto, J Carter, J Li, ...
US Patent 5,932,598, 1999
2171999
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
JJ Talley, TD Penning, PW Collins, DJ Rogier Jr, JW Malecha, ...
US Patent 5,760,068, 1998
2051998
Buprenorphine–an attractive opioid with underutilized potential in treatment of chronic pain
IK Khanna, S Pillarisetti
Journal of pain research, 859-870, 2015
1882015
Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1, 2-diarylimidazoles are potent, orally active antiinflammatory agents
IK Khanna, Y Yu, RM Huff, RM Weier, X Xu, FJ Koszyk, PW Collins, ...
Journal of Medicinal Chemistry 43 (16), 3168-3185, 2000
1462000
Pyrimidine compounds, process for their preparation and compositions containing them
M Pal, S Kalleda, S Padakanti, NK Swamy, KR Yeleswarapu, ...
US Patent 7,820,654, 2010
942010
Antimicrobial agents from higher plants: prenylated flavonoids and other phenols from Glycyrrhiza lepidota
LA Mitscher, GSR Rao, I Khanna, T Veysoglu, S Drake
Phytochemistry 22 (2), 573-576, 1983
851983
Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists
S Sasmal, G Balaji, HRK Reddy, D Balasubrahmanyam, G Srinivas, ...
Bioorganic & medicinal chemistry letters 22 (9), 3157-3162, 2012
772012
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
JJ Talley, TD Penning, PW Collins, DJ Rogier Jr, JW Malecha, ...
US Patent 5,563,165, 1996
771996
Facile, regioselective syntheses of N-alkylated 2, 3-diaminopyridines and imidazo [4, 5-b] pyridines
IK Khanna, RM Weier, KT Lentz, L Swenton, DC Lankin
The Journal of Organic Chemistry 60 (4), 960-965, 1995
731995
Convergent, parallel synthesis of a series of β-substituted 1, 2, 4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists
ML Boys, LA Schretzman, NS Chandrakumar, MB Tollefson, SB Mohler, ...
Bioorganic & medicinal chemistry letters 16 (4), 839-844, 2006
642006
Novel heterocyclic compounds as gata modulators
CW Alexander, D De, IK Khanna, S Pillarisetti
US Patent App. 12/553,623, 2010
602010
Pyridine compounds, process for their preparation and compositions containing them
M Pal, CW Alexander, I Khanna, J Iqbal, R Pillarisetti, S Maitra, ...
US Patent 7,622,486, 2009
592009
Substituted pyrazoles as p38 kinase inhibitors
A Anantanarayan, M Clare, PW Collins, JZ Crich, R Devraj, DL Flynn, ...
US Patent 6,423,713, 2002
592002
Methods for the treatment of diabetes-associated dyslipdemia
U Saxena, S Pillarisetti, I Khanna
US Patent 8,008,328, 2011
552011
Substituted pyrazoles as p38 kinase inhibitors
A Anantanarayan, M Clare, PW Collins, JZ Crich, R Devraj, DL Flynn, ...
US Patent 6,514,977, 2003
502003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20